JE

John Evans

North America, New York, United States, New York

Description

John Evans is the CEO of Beam Therapeutics. He attended The Wharton School.

Investor Profile

John Evans has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on File Sharing, Photography, Real Time.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (50%)

Industry Focus

  • File Sharing
  • Photography
  • Real Time
  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does John Evans frequently co-invest with?

DG VENTURES
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Bruker
North America, Massachusetts, United States, Billerica
Co-Investments: 1
HM
North America, California, United States, Palo Alto
Co-Investments: 1
UD
North America, New York, United States, New York
Co-Investments: 1
Olive Capital
North America, California, United States, San Francisco
Co-Investments: 1
MV
North America, California, United States, San Francisco
Co-Investments: 1
Brainstorm Ventures
North America, California, United States, San Francisco
Co-Investments: 1
True Ventures
North America, California, United States, Palo Alto
Co-Investments: 1

Which angels does John Evans often collaborate with?

MG
North America, California, United States, Palo Alto
Shared Deals: 1
JM
North America, Massachusetts, United States, Boston
Shared Deals: 1
AO
North America, California, United States, San Francisco
Shared Deals: 1
YL
North America, California, United States, San Francisco
Shared Deals: 1
GT
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by John Evans?

Terrain BioSciences accelerates RNA-based therapeutics and vaccine development using AI and proprietary platforms.

Biotechnology
SeedFeb 12, 2025
Amount Raised: $9,000,000
Kicksend

Mountain View, California, United States

Kicksend is an easy-to-use application to send, receive and print photo albums.

File SharingPhotographyReal Time
SeedApr 13, 2013
Amount Raised: $1,000,000